Switching to E-cigarettes in Smokers Not Interested in Quitting
Recruiting
Phase 3
Interventional Study
Smoking Reduction
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 21 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 500 (estimated)
- Sponsor
- University of Kansas Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objectives of this application are to 1) compare short- and long-term harm reduction and abuse liability potential of a nicotine salt pod-based electronic cigarettes (EC) in adult (AA) exclusive EC, dual cig-EC, and exclusive cig users, 2) characterize factors that predict who switches fully, partially, or not at all, and 3) examine if harm reduction can be further enhanced by treating dual us…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ≥ 21 years of age
* Smoke \>5 cigarettes per day
* Smoked cigarettes for \> 6 months
* Verified smoker (CO \> 5 ppm)
* Functioning telephone
* Interested in switching to EC
* Willing to take varenicline and complete all study visits
Exclusion Criteria:
* Interested in quitti…
Contacts